San Antonio Breast Cancer Symposium
|Several Canadian Cancer Trials Group abstracts will be presented at the 31st Annual San Antonio Breast Cancer Symposium
being held December 10-14, 2008 in San Antonio, Texas.
Chromosome 17 polysomy: A unifying hypothesis underlying benefit from adjuvant anthracyclines?
Bartlett JMS, Desmedt C, Munro A, O'Malley FP, Larsimont D, di Leo A, Cameron DA, Isola J, Shepherd L, Twelves CJ, Pritchard KI, for the HER2/TIIa Meta-analysis Group. Edinburgh University, Edinburgh, United Kingdom; HER2/TopoIIa Meta-Analysis Group, Brussels, Belgium.
Reductions in tumor RNA integrity associated with clinical response to epirubicin/docetaxel chemotherapy in breast cancer patients
Parissenti AM, Chapman J-AW, Kahn HJ, Guo B, Han L, O'Brien P, Clemons MP, Jong R, Dent R, Fitzgerald B, Pritchard KI, Shepherd LE, Trudeau ME. Sudbury Regional Hospital, Sudbury, ON, Canada; Canadian Cancer Trials Group, Kingston, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada.
Canadian Cancer Trials Group MA.17: hormone receptor expression of in-breast recurrences and contralateral primary breast cancers arising on aromatase inhibitors
Moy B, Tu D, Shepherd LE, Palmer MJ, Ingle JN, Goss PE. Massachusetts General Hospital, Boston, MA; Canadian Cancer Trials Group, Kingston, ON, Canada; Mayo Clinic, Rochester, MN.
31st Annual San Antonio Breast Cancer Symposium
An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.
December 10-14, 2008
Henry B. Gonzalez Convention Center, San Antonio, Texas